Cover Story Carole Goble: Democratizing Informatics for the ‘Long Tail’ Scientist Goble recently spoke to Bio•IT World editor-in-chief Kevin Davies about her mission to democratize informatics for life sciences.
Up Front The Complete Picture at Marco Island
Highlights include technology maturation from PacBio, Ion, and CGI.
[Sidebar] Sun Spots
EMD Serono Opens New Research Hub in Boston
EMD hopes people and technology will be key to idea generation.
The Psychology of ‘Smarter’ Drug Discovery
Four cognitive biases that might be slowing drug discovery.
‘Elementary, my dear Watson’
The Bush Doctrine | IBM’s Watson supercomputer is changing the way data interacts.
Growth Coming for Molecular Diagnostics
Insights Outlook | Molecular diagnostics market set to boom for bio-IT.
Clinical Trials A Stratified Approach to Rheumatoid Arthritis
Centocor focuses on biomarkers for inflammatory diseases, respiratory diseases.
goBalto’s Three Easy Steps to Study Startup
Tracker aims to reinvent study startup process.
Putting Medical Records Data Through its Paces
New partnership hopes facilitate clinical research with EMRs.
Next-Gen DataThe State of Mutation Curation
Databases sprout up to meet needs of clinical genomic informatics.
[Sidebar] Gene Data’s Aussie Rules
GenoLogics Eyes Next-Gen LIMS Market
A recent partnership with Illumina is taking the company to ‘another level.’
IT/WorkflowWill the Cloud Reign for Pharma?
Cloud-based portal for easy collaboration could seal the deal for pharma.
Wingu Makes Science Simple
‘Google for research’ organizes all of your info in one place.
In Every IssueEnding Diagnostic Odysseys
First Base | In Wisconsin, at least, genomic sequencing is already making itself known in the clinic. BY KEVIN DAVIES
FDA Works to Become More Transparent
The Russell Transcript | With its new online reporting feature, FDA hopes to pull back the curtain on its inner workings. BY JOHN RUSSELL
Genedata Announces Software Suite for Biologics R&D
Genedata Biologics automatically identifies the most promising screening hits based on assay readouts and sequence charactertistics.